HIV-Associated Lung Cancer

被引：16

作者：

Kiderlen, Til R. ^{[1
]}

Siehl, Jan ^{[2
]}

Hentrich, Marcus ^{[3
]}

机构：

[1] Vivantes Clin Neukolln, Dept Hematol Oncol & Palliat Care, Rudower Str 48, D-12351 Berlin, Germany

[2] Arzteforum Seestr, Berlin, Germany

[3] Red Cross Hosp Munich, Dept III Internal Med Hematol Oncol, Munich, Germany

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2017年 / 40卷 / 03期

关键词：

HIV; AIDS; Lung cancer; Non-AIDS-defining malignancy; ACTIVE ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY-VIRUS-INFECTION; HIV-1-INFECTED INDIVIDUALS; CIGARETTE-SMOKING; RISK; ERA; POPULATION; SURVIVAL; AIDS; DIAGNOSIS;

D O I：

10.1159/000458442

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Lung cancer (LC) is one of the most common non-AIDS (acquired immune deficiency syndrome)-defining malignancies. It occurs more frequently in persons living with human immunodeficiency virus (PLWHIV) than in the HIV-negitive population. Compared to their HIV negative counterparts, patients are usually younger and diagnosed at more advanced stages. The pathogenesis of LC in PLWHIV is not fully understood, but immunosuppression i'pri combination with chronic infection and the oncogenic effects of smoking and HIV itself all seem to play a role. Currently, no established preventive screening is available, making smoking cessation the most promisi1ng preventive measure. Treatment protocols and standards are the same as for the general population. Notably, immuno-oncology will also become standard of care in a significant subset of HIV-infected patients with;LC. As drug interactions and hematological toxicity must be taken into account, a multidisciplinary approach should include a physician experienced in the treatment of HIV. Only limited data is available on novel targeted therapies and checkpoint inhibitors in the setting of HIV. (C) 2017 S. Karger GmbH, Freiburg

引用

页码：88 / 92

页数：5

共 69 条

[1] Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening [J].

Aberle, Denise R. ;

Adams, Amanda M. ;

Berg, Christine D. ;

Black, William C. ;

Clapp, Jonathan D. ;

Fagerstrom, Richard M. ;

Gareen, Ilana F. ;

Gatsonis, Constantine ;

Marcus, Pamela M. ;

Sicks, JoRean D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (05) :395-409

[2] Three-dimensional model of human TIP30, a coactivator for HIV-1 Tat-activated transcription, and CC3, a protein associated with metastasis suppression [J].

Baker, ME ;

Yan, L ;

Pear, MR .

CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (05) :851-858

[3]

Bearz A, 2014, EUR REV MED PHARMACO, V18, P500

[4] Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002 [J].

Bedimo, R ;

Chen, RY ;

Accortt, NA ;

Raper, JL ;

Linn, C ;

Allison, JJ ;

Dubay, J ;

Saag, MS ;

Hoesley, CJ .

CLINICAL INFECTIOUS DISEASES, 2004, 39 (09) :1380-1384

[5] Survival after cancer diagnosis in persons with AIDS [J].

Biggar, RJ ;

Engels, EA ;

Ly, S ;

Kahn, A ;

Schymura, MJ ;

Sackoff, J ;

Virgo, P ;

Pfeiffer, RM .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 39 (03) :293-299

[6] Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy [J].

Bonnet, F ;

Lewden, C ;

May, T ;

Heripret, L ;

Jougla, E ;

Bevilacqua, S ;

Costagliola, D ;

Salmon, D ;

Chêne, G ;

Morlat, P .

CANCER, 2004, 101 (02) :317-324

[7] HIV-related lung cancer in the era of highly active antiretroviral therapy [J].

Bower, M ;

Powles, T ;

Nelson, M ;

Shah, P ;

Cox, S ;

Mandelia, S ;

Gazzard, B .

AIDS, 2003, 17 (03) :371-375

[8] Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: Implications for patient care [J].

Brock, Malcolm V. ;

Hooker, Craig M. ;

Engels, Eric A. ;

Moore, Richard D. ;

Gillison, Maura L. ;

Alberg, Anthony J. ;

Keruly, Jeanne C. ;

Yang, Stephen C. ;

Heitmiller, Richard F. ;

Baylin, Stephen B. ;

Herman, James G. ;

Brahmer, Julie R. .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 43 (01) :47-55

[9] Tobacco use and readiness to quit smoking in low-income HIV-infected persons [J].

Burkhalter, JE ;

Springer, CM ;

Chhabra, R ;

Ostroff, JS ;

Rapkin, BD .

NICOTINE & TOBACCO RESEARCH, 2005, 7 (04) :511-522

[10] Immunosuppression and cancer: A comparison of risks in recipients of organ transplants and in HIV-positive individuals [J].

Busnach, G. ;

Piselli, P. ;

Arbustini, E. ;

Baccarani, U. ;

Burra, P. ;

Carrieri, M. P. ;

Citterio, F. ;

De Juli, E. ;

Bellelli, S. ;

Pradier, C. ;

Rezza, G. ;

Serraino, D. .

TRANSPLANTATION PROCEEDINGS, 2006, 38 (10) :3533-3535

← 1 2 3 4 5 6 7 →